Ultrasound: Page 257

AIUM forum touts 'ultrasound first' to boost use of modality
By Cynthia E. Keen
Ultrasound is an underutilized diagnostic imaging exam, according to the American Institute of Ultrasound in Medicine (AIUM), which organized a forum to promote the concept of performing "ultrasound first" when clinically indicated. But what will it take to make this happen?
November 14, 2012
2012 11 14 12 43 14 437 Ultrasound First Logo 70
CAD may improve breast ultrasound specificity
By Erik L. Ridley
Wednesday, November 28 | 3:00 p.m.-3:10 p.m. | SSM01-01 | Arie Crown TheaterThis scientific session will describe how a computer-aided detection (CAD) scheme can help distinguish between benign and malignant masses on breast ultrasound exams.
November 13, 2012
Shear-wave elastography improves breast US specificity
By Kate Madden Yee
Tuesday, November 27 | 5:00 p.m.-5:30 p.m. | LL-BRS-TU1C | Lakeside Learning CenterShear-wave elastography improves breast ultrasound's ability to distinguish benign from malignant solid breast nodules, according to a study by researchers from the University of Toronto.
November 13, 2012
'White wall' characteristic on ABUS indicates benign lesion
By Kate Madden Yee
Tuesday, November 27 | 3:40 p.m.-3:50 p.m. | SSJ01-05 | Arie Crown TheaterAn echogenic "white wall" in a hypoechoic lesion visualized on automated breast ultrasound (ABUS) suggests a benign lesion, and patients may not need to be recalled for further evaluation, according to researchers from George Washington University Medical Center.
November 13, 2012
ABUS boosts mammography's performance
By Kate Madden Yee
Tuesday, November 27 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown TheaterWhat does automated breast ultrasound (ABUS) contribute to cancer screening when it's used with mammography in women with dense breasts? Researchers from the University of Chicago will present findings that address this question on Tuesday afternoon.
November 13, 2012
US-guided core-needle breast biopsy OK for preop staging
By Kate Madden Yee
Tuesday, November 27 | 3:20 p.m.-3:30 p.m. | SSJ01-03 | Arie Crown TheaterWhich is better for assessing metastasis in newly diagnosed breast cancer: fine-needle aspiration or core biopsy? It's an important question, according to Finnish researchers, as the presence of axillary metastasis is the most significant prognostic factor in invasive breast cancer.
November 13, 2012
Triple-negative breast cancer shows specific US characteristics
By Kate Madden Yee
Tuesday, November 27 | 3:10 p.m.-3:20 p.m. | SSJ01-02 | Arie Crown TheaterCertain ultrasound characteristics can help clinicians identify triple-negative breast cancer, researchers from Chile will report in this scientific session.
November 13, 2012
ABUS detects suspicious lesions found on breast MRI
By Kate Madden Yee
Tuesday, November 27 | 3:00 p.m.-3:10 p.m. | SSJ01-01 | Arie Crown TheaterAutomated breast ultrasound (ABUS) could prove helpful for evaluating additional suspicious lesions identified by breast MRI, and it's faster and more cost-effective than handheld second-look ultrasound, according to a study that will be presented on Tuesday afternoon.
November 13, 2012
US matches MRI in identifying lesions seen on BSGI
By Kate Madden Yee
Monday, November 26 | 10:00 a.m.-10:10 a.m. | VSMI21-08 | Arie Crown TheaterMore than 50% of lesions seen on breast-specific gamma imaging (BSGI) can also be visualized with targeted ultrasound -- a percentage comparable to MRI results, according to researchers from George Washington University.
November 13, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 13, 2012
Annual breast US benefits women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterSince the 2009 passage of the breast density notification law in Connecticut, radiologists have a legal obligation to inform patients with mammographically dense breast tissue that they may benefit from the addition of screening breast ultrasound. But how effective is that second round of screening?
November 13, 2012
ABUS plus mammography finds cancer early in women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:05 a.m.-11:15 a.m. | SSA01-03 | Arie Crown TheaterScreening with automated breast ultrasound (ABUS) -- as an adjunct to digital mammography -- detects early-stage, node-negative invasive carcinoma in asymptomatic women with dense breast tissue, according to researchers from George Washington University Medical Center. And finding these cancers could reduce breast cancer mortality rates.
November 13, 2012
Previous Page
Page 257 of 527
Next Page